top of page
Screenshot 2024-08-14 at 10.09.02-02.png

AI-Driven Case Intake

Before and After TheraLyze.jpg

Eliminate Manual Data Entry and Reduce Case Processing time.

Screenshot 2024-08-14 at 14.13.20-2.png

Save costs, time, enhance speed and empower Case Processors

Screenshot 2024-08-14 at 10.16.43-2.png

What we do

TheraLyze.ai revolutionizes case intake by eliminating manual data entry and significantly reducing the total time spent on processing and submitting cases to regulators.

Use Case

CROs and pharmaceutical companies use TheraLyze.ai to automate case intake, extract key data, generate E2B R3 files, and integrate seamlessly with pharmacovigilance databases.

How it works

Users upload raw safety data to TheraLyze.ai, which processes the files using AI, extracts relevant information, and generates structured E2B R3 files ready for submission to any PV Database for regulatory authorities.
HowItworks.png

Let’s Talk - Contact Us

Get ahead of AI today

Let’s explore how TheraLyze.ai can transform your pharmacovigilance workflows.

Profile.jpeg

Founder, CEO

Sunil Kulkarni, founder & CEO of TheraLyze.ai, leverages deep expertise in technology and life sciences. Formerly a leader at Veeva Systems, he specializes in AI, machine learning, and scalable tools & solutions to save time, streamline workflows, boost quality, and ensure compliance.
bottom of page